News April 30th, 2019 - Nijmegen (NL) Enzyre, which is developing breakthrough ambulant diagnostic technology for coagulation testing, announces today the appointment of Dirk Pollet as Chief Executive Officer. It also announces the award of €2M European Fund for Regional Development (EFRO) grant and closing of a successful seed funding round which enables Enzyre to accelerate the development of its unique Hemophilia Biochip technology.
Enzyre’s platform technology requires just a small volume of blood and is able to measure up to twelve reactions simultaneously with high sensitivity and specificity, that can be carried out at home, on the road or in a critical care setting, without any laboratory infrastructure. This has the potential for better disease management and to improve the lives of patients living with chronic conditions whilst reducing healthcare costs.
News April 26th, 2019 - Nijmegen (NL) Enzyre, drie jaar geleden gestart als een spin-off van het Radboudumc, ontvangt een EFRO-subsidie van twee miljoen euro voor het ontwikkelen van een biochip waarmee hemofiliepatiënten met een paar druppels bloed hun eigen stollingswaarde direct kunnen meten. Hiermee is het mogelijk de medicijnopname te optimaliseren.
Enzyre opening new office and laboratory facilities
News March 30th, 2018 - Nijmegen (NL) 30th of March: Enzyre officially opened their new office and laboratory facilities at the Novio Tech Campus, where they had subleased workspace the past year. The new facilities were opened by Michiel Scheffer, Member of the Executive Board of the Province Gelderland, in the presence of a delegation of The Economic Board and Members of the Dutch Parliament.
Award Anneke Sijbers
News March 29th, 2018 - Nijmegen (NL) 29th of March: Anneke Sijbers received Enzyre's first award of € 10,000 during a MedtechPartners meeting celebrating their 10-year anniversary.
Receiving the first multisensor wafer
News February 1st, 2018 - Nijmegen (NL) February 1st CSO Waander van Heerde from Enzyre received the first multisensor NXP wafer from Frank Wennekes, process development / program manager of NXP. This wafer contains an optical sensor, one of the key elements for the integrated microfluidic cartridge for the Enzyre biochip platform. The optical sensors will be used in combination with Enzyres proprietary chemiluminescence technology to measure enzymatic reactions.